MindBio Announces Closing of Private Placement

Vancouver, British Columbia – April 1, 2026 – TheNewswire -  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF)  (the “ Company ” or “ MindBio ”), a biotechnology company that is commercialising prediction technologies for drug and alcohol intoxication detection using speech analytics and artificial intelligence, is pleased to announce that it has closed its previously announced upsized non-brokered private placement (the “ Offering ”) for gross proceeds of $1,437,828.87